Navigation Links
Regeneron Announces FDA Approval of EYLEA™ (aflibercept) Injection for the Treatment of Wet Age-Related Macular Degeneration
Date:11/18/2011

products and drug candidates, competing drugs that may be superior to EYLEA and Regeneron's products and drug candidates, uncertainty of market acceptance of EYLEA and Regeneron's products and drug candidates, unanticipated expenses, the availability and cost of capital, the costs of developing, producing, and selling products, the potential for any license or collaboration agreement, including Regeneron's agreements with Sanofi and Bayer HealthCare, to be canceled or terminated without any product success, and risks associated with third party intellectual property and pending or future litigation relating thereto.  A more complete description of these and other material risks can be found in Regeneron's filings with the United States Securities and Exchange Commission, including its Form 10-K for the year ended December 31, 2010 and Form 10-Q for the quarter ended September 30, 2011.  Regeneron does not undertake any obligation to update publicly any forward-looking statement, whether as a result of new information, future events, or otherwise, unless required by law.

Contact Information:   Michael Aberman, M.D. Peter Dworkin Investor Relations  Corporate Communications 914.847.7799 914.847.764 michael.aberman@regeneron.com peter.dworkin@regeneron.com
'/>"/>

SOURCE Regeneron Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Sanofi and Regeneron Report Positive Preliminary Phase 2 Program Results for Anti-PCSK9 Antibody in Hypercholesterolemia
2. Regeneron Pharmaceuticals Announces Pricing of Offering of Convertible Senior Notes due October 1, 2016
3. Regeneron Ranked by Science Magazine as the #2 Employer in the Global Biopharmaceutical Industry
4. Regeneron Announces Clinical Presentations at ASRS 2011 Annual Meeting
5. Regeneron Reports Second Quarter 2011 Financial and Operating Results
6. Sanofi and Regeneron Report Positive Phase 2b Trial Results with Sarilumab in Rheumatoid Arthritis
7. Trading in Regeneron Common Stock Halted
8. Regeneron Reports First Quarter 2011 Financial and Operating Results
9. Regeneron Announces Presentation at the Bank of America Merrill Lynch 2011 Health Care Conference
10. Regeneron and Bayer Report Positive Results for VEGF Trap-Eye in Second Phase 3 Study in Central Retinal Vein Occlusion
11. Regeneron and Bayer Announce Start of Phase 3 Clinical Program in Diabetic Macular Edema
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... SAN DIEGO , July 1, 2015 /PRNewswire/ ... pharmaceutical company focused on the development and commercialization ... the company will ring The Nasdaq stock market ... is celebrating the growing success of its Go ... Over 3.6 million cataract procedures are performed annually ...
(Date:7/1/2015)... Lupin , ... Number of MPP Sub-licensees to Fourteen Companies   ... the rapid expansion of its network of generic manufacturers to ... develop MPP-licensed antiretrovirals (ARVs). New companies Lupin and Strides Arcolab ... HIV medicine the MPP licensed from ViiV Healthcare two months ...
(Date:7/1/2015)... N.J. , July 1, 2015  Celsion Corporation ... today announced that Michael H. Tardugno , Chairman, ... Cantor Fitzgerald,s Inaugural Healthcare Conference on Wednesday, July 8, ... held at Le Parker Meridien Hotel located at 119 ... 10019. A copy of the presentation ...
Breaking Medicine Technology:Imprimis Pharmaceuticals to Ring The Nasdaq Stock Market Closing Bell 2Imprimis Pharmaceuticals to Ring The Nasdaq Stock Market Closing Bell 3Imprimis Pharmaceuticals to Ring The Nasdaq Stock Market Closing Bell 4The Medicines Patent Pool Increases its Generic Manufacturing Network to Ramp-Up Production of Low Cost Antiretrovirals (ARVs) 2The Medicines Patent Pool Increases its Generic Manufacturing Network to Ramp-Up Production of Low Cost Antiretrovirals (ARVs) 3Celsion Corporation to Present at Cantor Fitzgerald's Inaugural Healthcare Conference on July 8, 2015 2
... LAS VEGAS, Jan. 10, 2012 What: ... the Consumer Electronics Show (CES) in Las Vegas.  The Ion ... one day for $1,000 When:   Tuesday, ... hours Where:   Las Vegas Convention Center, ...
... Jan. 10, 2012   Reportlinker.com announces that a new ... The Outlook for Medical Devices ... .html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Devices 66 Key Markets Covered ... device market will approach US$350 billion, an annual ...
Cached Medicine Technology:The Outlook for Medical Devices Worldwide 2
(Date:7/1/2015)... ... 01, 2015 , ... During the first week of June, ... and Development) and Chuck Corso (Associate Sales Trainer) participated in the 44th Annual ... together learning and development professionals from more than 300 life sciences companies around ...
(Date:7/1/2015)... , ... - (PRWEB) July 01, 2015 , ... Lisa ... nationwide virtual 5K on August 15-16th (MSG Keys’ birthday) in memory of her late ... highly decorated soldier and recipient of the Bronze Star Medal, died during a Special ...
(Date:7/1/2015)... ... July 01, 2015 , ... “Well-meaning social policy often has ... in FIU’s School of International and Public Affairs. , The researchers ... the National Survey on Drug Use and Health, which is a nationally representative ...
(Date:7/1/2015)... West Orange, NJ (PRWEB) , ... July 01, 2015 , ... Scoliosis is a disorder ... to the National Scoliosis Foundation, it affects 2 to 3 percent of the population, or ... ages, scoliosis most often develops in children between the ages of 10 and 15. Most ...
(Date:7/1/2015)... ... 01, 2015 , ... Boar’s Head Brand®, one of the ... Independence Day celebrations with new takes on classic dishes. From chicken salad with ... any summertime get together. , “Celebrating with family, friends, and great food is ...
Breaking Medicine News(10 mins):Health News:Mission Pharmacal Company: Alamo Pharma Services' Training Leaders Take Steps to Further Expand Capabilities for Mission Pharmacal and Other Clients 2Health News:Mission Pharmacal Company: Alamo Pharma Services' Training Leaders Take Steps to Further Expand Capabilities for Mission Pharmacal and Other Clients 3Health News:Mission Pharmacal Company: Alamo Pharma Services' Training Leaders Take Steps to Further Expand Capabilities for Mission Pharmacal and Other Clients 4Health News:Wife of Fallen Special Forces Soldier to Host Nationwide ‘Virtual 5K’ for Charity 2Health News:Wife of Fallen Special Forces Soldier to Host Nationwide ‘Virtual 5K’ for Charity 3Health News:Researchers find that medical marijuana laws increase recreational marijuana use among juveniles 2Health News:Scoliosis: A Guide for Parents from Orthopedic Surgeon Dr. Fabien Bitan 2Health News:Scoliosis: A Guide for Parents from Orthopedic Surgeon Dr. Fabien Bitan 3Health News:Scoliosis: A Guide for Parents from Orthopedic Surgeon Dr. Fabien Bitan 4Health News:Boar’s Head Helps Craft a Delicious Independence Day 2Health News:Boar’s Head Helps Craft a Delicious Independence Day 3
... , NEW YORK , ... that FINRA has determined that the ex-dividend date will be January ... by its Board of Directors on December 23, 2009 . The ... to trade without the right to receive the dividend payment. The cash ...
... and DC to gather on Tuesday morning at the corner of the ... sweet irony of the ,Ted Kennedy seat, sending health care to the ... almost like electing Saint Michael to govern hell." , WASHINGTON ... Randall Terry , Director, Operation Rescue Insurrecta Nex: , Time: ...
... , ASHEVILLE, N.C. , Jan. 19 ... companies are working hard to adjust their recipes to find ways to ... option that is all natural, low in sodium—40% to 70% less than ... and only natural low sodium sea salt. Total sales that year did ...
... Jan. 19 Speaker Nancy Pelosi , House Majority ... held a press availability this afternoon in the Capitol following a Democratic ... Pelosi: Good afternoon. , As you may be aware, we just ... that I know you,re aware of in Massachusetts and the ...
... Finding moves research closer to helping people with spinal injuries, ... Transplanted neurons grown from embryonic stem cells were able to ... , Researchers from Stanford Medical School say their study was ... to become specific brain cells and to link correctly in ...
... , TUESDAY, Jan. 19 (HealthDay News) -- The majority of ... Near East 10,000 years ago, say English researchers who ... from father to son. , "We focused on the commonest ... -- it follows a gradient from south-east to north-west, reaching ...
Cached Medicine News:Health News:Southridge Funds Facilitate Special Capital Distribution for Technest Shareholders 2Health News:Ocean's Flavor Natural Sea Salt is Helping Companies Reach Low Sodium Goals 2Health News:Ocean's Flavor Natural Sea Salt is Helping Companies Reach Low Sodium Goals 3Health News:Transcript of Pelosi, House Democratic Leaders' Press Availability Today Following Leadership Meeting 2Health News:Transcript of Pelosi, House Democratic Leaders' Press Availability Today Following Leadership Meeting 3Health News:Stem Cells Become Functioning Neurons in Mice 2
... and Mini Step™ device components are supplied sterile. ... Use System is supplied sterile in 2/3, 5, ... various configurations and combinations. They are used in ... and the Step™ radially Expandable Sleeve. The 5, ...
... Premium One-Step™ single-use system device is comprised ... device components for creating each access port ... , Step™ insufflation and access needle, ... separately. , Step™ radially expandable sleeve, 100 ...
BLUNTPORT Plus Single Use Converterless 5 mm - 12 mm Trocar System for Open Laparoscopy....
... PLUS V2 RT single-use obturator has a sharp ... ,The Auto Suture™ VERSAPORT™ PLUS V2 RT ... 11 mm and 12 mm diameters with a ... 5 mm short single-use obturators are not available ...
Medicine Products: